Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose Intolerance

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Ritter Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01113619
First received: April 23, 2010
Last updated: December 6, 2011
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2011
  Primary Completion Date: October 2011 (Final data collection date for primary outcome measure)
No publications provided by Ritter Pharmaceuticals, Inc.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):